Versant Capital Management’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$38.2K	Buy	1,328 +1,238	+1,376%	+$35.6K	0.01%	1135
2025 Q1	$3.02K	Buy	+90	New	+$3.02K	﹤0.01%	2198
2023 Q3	–	Sell	-31	Closed	-$559	–	1958
2023 Q2	$559	Buy	+31	New	+$559	﹤0.01%	1809